BioPorto (BIOPOR)

Copenhagen
1.144
+0.012(+1.06%)
  • Volume:
    101,296
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.140 - 1.170
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0011048619
  • S/N:334693005

BIOPOR Overview

Prev. Close
1.132
Day's Range
1.14-1.17
Revenue
25.18M
Open
1.144
52 wk Range
1.002-4.1
EPS
-0.49
Volume
101,296
Market Cap
382.87M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
451,170
P/E Ratio
-
Beta
1.11
1-Year Change
-68.4%
Shares Outstanding
334,680,005
Next Earnings Date
16 Aug 2022
What is your sentiment on BioPorto?
or
Market is currently closed. Voting is open during market hours.

BioPorto Company Profile

BioPorto Company Profile

Employees
28
Market
Denmark

Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsSellNeutralStrong BuySellStrong Sell
SummaryStrong SellSellStrong SellSellStrong Sell